Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 31;13(2):91-93.
doi: 10.4103/jgid.jgid_316_20. eCollection 2021 Apr-Jun.

Evaluation of COVID-19 Antigen Fluorescence Immunoassay Test for Rapid Detection of SARS-CoV-2

Affiliations

Evaluation of COVID-19 Antigen Fluorescence Immunoassay Test for Rapid Detection of SARS-CoV-2

Vandana Vijayeta Kiro et al. J Glob Infect Dis. .

Abstract

Introduction: Tests detecting SARS-CoV-2-specific antigen have recently been developed, and many of them are now commercially available. However, the real-world performance of these assays is uncertain; therefore, their validation is important. In this study, we have evaluated the performance of STANDARD F COVID-19 antigen fluorescence immunoassay (FIA) kit.

Methods: Nasopharyngeal samples collected from patients were subjected to the test as per manufacturer's instructions. The performance of the kit was compared with the gold standard real-time polymerase chain reaction.

Results: A total of 354 patients were tested with STANDARD F COVID-19 antigen FIA test kit. The overall sensitivity, specificity, positive predictive value, and negative predictive value of this test were found to be 38%, 99%, 96.2%, and 72%, respectively, with a diagnostic accuracy of 75.7%.

Conclusion: STANDARD F COVID-19 antigen FIA showed high specificity and positive predictive value but low sensitivity and negative predictive value.

Keywords: Analyzer; COVID-19; SARS-CoV-2; fluorescence immunoassay; rapid antigen test.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Receiver operator curve: Performance of antigen fluorescence immunoassay test

References

    1. [Last updated on 2020 Jul 18]. Available from: https://www.bloomberg.com/graphics/2020-coronavirus-cases-world-map/Mapp... .
    1. World Health Organization. Co-ordinated Global Research Roadmap. [Last accessed on 2020 May 15]. Available from: https://www.who.int/who-documents-detail/acoordinated-global-research-ro...
    1. Chen Y, Liu Q, Guo D, et al. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol. 2020;92:418–23. - PMC - PubMed
    1. Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun. 2020;11:1620. - PMC - PubMed
    1. Lee CY, Lin RT, Renia L, Ng LF. Serological approaches for COVID-19: Epidemiologic perspective on surveillance and control. Front Immunol. 2020;11:879. - PMC - PubMed